Drug company Lupin gets U.S. approval for new medicine tablets
Indian drug maker Lupin received official permission from the United States to sell Pitolisant tablets in the American market.
What is happening
A big drug company named Lupin has good news today. The health authorities in the United States, known as the US FDA, gave them official permission to sell their new medicine. These are called Pitolisant tablets, and they are used to help people with specific health problems.
Why this matters
Getting approval from the United States is a huge step for any medicine company. It means the medicine has passed strict safety and quality tests. For Lupin, this means they can now sell their product in American stores, which helps the company grow and earn more money.
- Lupin received official nod from the US FDA.
- The approved product is Pitolisant tablets.
- This allows the company to sell medicine in the US.
What happens next
Lupin will now start making and shipping these medicine tablets to the United States. Patients in America who need this treatment will soon be able to buy it. Company leaders hope this new product will do very well in the global market.